---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-000241"
form_type: "8-K"
ticker: "ACON"
cik: "0001635077"
company_name: "Aclarion, Inc."
filed_at: "2026-01-13T23:59:59+00:00"
generated_at: "2026-05-16T10:40:28.395431+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aclarion closes $10.4M equity offering, reports $21.6M cash, zero debt, runway into 2028

## Summary
- Closed $10.4M common-stock-only offering at $5.18/share; includes 200,000 shares and pre-funded warrants for 1.8M shares.
- Cash balance $21.6M as of Jan 12, 2026; zero debt.
- Cash runway extended into 2028 based on current operating plans.
- Plans to accelerate CLARITY trial enrollment, launch Nociscan v2.8 in Q1'26, and pursue payer coverage.
- Dawson James Securities acted as exclusive placement agent.

## SEC filing metadata
- accession: 0001683168-26-000241
- form_type: 8-K
- ticker: ACON
- cik: 0001635077
- company_name: Aclarion, Inc.
- filed_at: 2026-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635077/000168316826000241/0001683168-26-000241-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635077/000168316826000241/aclarion_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-000241
- JSON: https://secwatch.observer/filing/0001683168-26-000241.json
- Plain text: https://secwatch.observer/filing/0001683168-26-000241.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.